Sagiment Biosciences Quote - SGMT

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

3.93

Bid

3.00

Offer

19.86

Volume

384,164

3.85 Day's Range 4.05

2.13 52 Week Range 20.71

Market Cap

119.142M

Previous Close

3.89

Open

3.89

Last Trade

4.06

Last Trade Time

Financial Volume

US$ 1,508,030

VWAP

3.9255

Average Volume (3m)

516,863

Shares Outstanding

30,393,397

Dividend Yield

PE Ratio

-4.27

Earnings Per Share (EPS)

-0.92

Revenue

Net Profit

-27.88M

Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional lipid metabolism pathways. Its lead drug candidate is Denifanstat, a FASN inhibitor for the treatment ... Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional lipid metabolism pathways. Its lead drug candidate is Denifanstat, a FASN inhibitor for the treatment of nonalcoholic steatohepatitis and acne. The company is also developing TVB-3567, a FASN inhibitor for the treatment of various types of cancers. The company was formerly known as 3-V Biosciences, Inc. and changed its name to Sagimet Biosciences Inc. in August 2019. Sagimet Biosciences Inc. was incorporated in 2006 and is headquartered in San Mateo, California. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Headquarters

Camden, Delaware, USA

Founded

1970

Sagiment Biosciences Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SGMT. The last closing price for Sagiment Biosciences was US$3.89. Over the last year, Sagiment Biosciences shares have traded in a share price range of US$ 2.13 to US$ 20.71.

Sagiment Biosciences currently has 30,393,397 shares in issue. The market capitalisation of Sagiment Biosciences is US$119.14 million. Sagiment Biosciences has a price to earnings ratio (PE ratio) of -4.27.

Period †	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.66	-14.3790849673	4.59	4.68	3.71	564812	4.06846245	CS
4	-0.86	-17.9540709812	4.79	5.7	3.71	637638	4.84091541	CS
12	-1.7	-30.1953818828	5.63	5.825	3.71	516863	4.71989619	CS
26	-1.605	-28.9972899729	5.535	20.71	3.71	1107177	9.8059335	CS
52	-11.57	-74.6451612903	15.5	20.71	2.13	649802	9.7253061	CS
156	-11.57	-74.6451612903	15.5	20.71	2.13	649802	9.7253061	CS
260	-11.57	-74.6451612903	15.5	20.71	2.13	649802	9.7253061	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
ME1OEMelodiol Global Health Ltd	AUD 0.006 (100.00%)	34
K2FK2fly Limited	AUD 0.1825 (82.50%)	2.49M
PRXProdigy Gold NL	AUD 0.003 (50.00%)	100.11k
ARVOCArtemis Resources Limited	AUD 0.003 (50.00%)	1.05M
MTBMount Burgess Mining Nl	AUD 0.0015 (50.00%)	5.38k
BNROBulletin Resources Limited	AUD 0.001 (-66.67%)	100k
FRSOAForrestania Resources Ltd	AUD 0.006 (-57.14%)	26k
GGEOAGrand Gulf Energy Limited	AUD 0.001 (-50.00%)	2.18M
D2OOADuxton Water Limited	AUD 0.021 (-47.50%)	4.5k
CT1Constellation Technologies Limited	AUD 0.002 (-33.33%)	50.02k
REDRed 5 Limited	AUD 0.4175 (3.09%)	135.31M
BGLBellevue Gold Limited	AUD 1.835 (-1.34%)	81.32M
NICNickel Industries Ltd	AUD 0.825 (-3.23%)	62.62M
S32South32 Limited	AUD 3.74 (1.77%)	56.22M
CXOCore Lithium Ltd	AUD 0.0855 (-6.04%)	56.06M